| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| Puxitatug Samrotecan | AZD8205; AZD-8205 | Phase 3 Clinical | Astrazeneca Plc | Biliary Tract Neoplasms; Breast Neoplasms; Carcinoma, Adenoid Cystic; Carcinoma, Non-Small-Cell Lung; Cholangiocarcinoma; Endometrial Neoplasms; Neoplasm Metastasis; Ovarian Neoplasms; Solid tumours; Triple Negative Breast Neoplasms | Details |
| Mocertatug Rezetecan | HS-20089; GSK-5733584; GSK5733584 | Phase 3 Clinical | Shanghai Hansoh Biomedical Co Ltd | Breast Neoplasms; Endometrial Neoplasms; Fallopian Tube Neoplasms; Genital Neoplasms, Female; Neoplasms; Ovarian Neoplasms; Peritoneal Neoplasms; Prostatic Neoplasms; Solid tumours; Stomach Neoplasms; Triple Negative Breast Neoplasms | Details |
| ABL-103 | ABL-103 | Phase 2 Clinical | Abl Bio Inc, Handok Inc | Solid tumours | Details |
| MHB-009C | MHB-009C; MHB009C | Phase 2 Clinical | Minghui Pharmaceutical (Hangzhou) Co Ltd | Solid tumours | Details |
| GEN-1047 | GEN-1047 | Phase 2 Clinical | Genmab A/S | Endometrial Neoplasms | Details |
| DB-1312 | BG-C9074; DB-1312 | Phase 1 Clinical | Duality Biologics (Suzhou) Co Ltd | Solid tumours | Details |
| LNCB-74 | LNCB-74; LNCB74; LCB41A | Phase 1 Clinical | LigaChem Biosciences Inc, Nextcure Inc | Biliary Tract Neoplasms; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Endometrial Neoplasms; Neoplasms; Ovarian Neoplasms; Solid tumours | Details |
| XKH-002 | XKH-002; XKH002 | Phase 1 Clinical | Beijing Kanova Biomedical Technology Co Ltd, Zhejiang Kanova Biopharmaceutical Co Ltd | Neoplasms; Solid tumours | Details |
| Felmetatug vedotin | SGN-B7H4V; PF-08046048; SGN-B-7H-4V; SGNB-7H4V; SGNB-7H-4V | Phase 1 Clinical | Seagen Inc | Breast Neoplasms; Carcinoma, Adenoid Cystic; Carcinoma, Non-Small-Cell Lung; Cholangiocarcinoma; Endometrial Neoplasms; Fallopian Tube Neoplasms; Gallbladder Neoplasms; Ovarian Neoplasms; Peritoneal Neoplasms; Solid tumours; Triple Negative Breast Neoplasms | Details |
| Emiltatug Ledadotin | XMT-1660 | Phase 1 Clinical | Mersana Therapeutics Inc | Abdominal Neoplasms; Breast Neoplasms; Carcinoma, Adenoid Cystic; Endometrial Neoplasms; Fallopian Tube Neoplasms; Neoplasms; Ovarian Neoplasms; Triple Negative Breast Neoplasms | Details |
| HBM-7008 | HBM7008; HBM-7008; R-7008; CLN-418 | Phase 1 Clinical | Harbour Biomed | Solid tumours | Details |
